Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00504127 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee
A Phase 3 study, sponsored by NicOx.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,020
- Enrollment target
NCT00504127 is a Phase 3 study that has completed, run by NicOx. The registered enrollment target is 1,020 participants.
The verdict
NCT00504127, a Phase 3 study, has completed, sponsored by NicOx.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,020 participants
- Enrollment target
Study Summary
To study of efficacy and safety of Naproxcinod vs. Naproxen and Placebo in the indication of signs and symptoms of osteoarthritis
Interventions
- DRUG placebo
- DRUG Naproxcinod 375 mg bid
- DRUG Naproxcinod 750 mg bid
- DRUG Naproxen 500 mg bid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,020 participants |
| Start Date | 2007-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00504127
The ClinicalTrials.gov registry entry for NCT00504127 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,020 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NicOx, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which placebo is the first listed.
NCT00504127 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00504127 about?
NCT00504127 is a clinical study titled "Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee". To study of efficacy and safety of Naproxcinod vs. Naproxen and Placebo in the indication of signs and symptoms of osteoarthritis
What is the current status of trial NCT00504127?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,020 participants. The study started on 2007-04.
What interventions are being tested in trial NCT00504127?
The interventions under investigation include: placebo (DRUG), Naproxcinod 375 mg bid (DRUG), Naproxcinod 750 mg bid (DRUG), Naproxen 500 mg bid (DRUG).
Who is sponsoring clinical trial NCT00504127?
This trial is sponsored by NicOx, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.